Frontlight ResearchEarly access
Trial site
Texas Institute of Cardiology
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Heart failure4 trials
- Obesity3 trials
- Coronary artery disease2 trials
- Atrial fibrillation1 trial
- Long COVID and ME/CFS1 trial
- Postural tachycardia syndrome (POTS)1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 310 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Completed6 trials
- Recruiting5 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Amgen5 trials
- Ionis Pharmaceuticals, Inc.3 trials
- Boehringer Ingelheim2 trials
- American Heart Association1 trial
- argenx1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure3 recruiting
- Obesity3 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Recruiting
Completed
Completed
Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS
Completed
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026